首诊帕金森病患者恐惧疾病进展疾病影响因素的纵向研究

doi:10.19854/j.cnki.1008-2425.2025.02.0002

摘要/Abstract

摘要： 目的探究首诊帕金森患者恐惧疾病进展疾病影响因素的纵向研究。方法本研究为纵向研究,选择2020年1月~2023年12月于我院收治并明确首诊为帕金森患者为研究对象,采用一般资料问卷调查表分别于第一次为首次确诊(T1)、确诊后2个月(T2)、确诊后4个月(T3)、确诊后6个月(T4)追踪随访调查,以潜类别模型识别首诊帕金森病患者恐惧疾病进展变化轨迹,并用Logistic回归分析患者恐惧疾病进展轨迹的影响因素。结果根据首诊帕金森病患者恐惧疾病进展得分变化轨迹共识别出2条,高水平疾病进展恐惧缓慢下降组占比59.35%(92/155),中水平恐惧疾病进展稳定组占比40.65%(63/155)。Logistic回归分析结果显示,以中-稳定组作为参照物,高疾病进展恐惧缓慢下降组患者年龄、PSQI评分、H＆Y 分级、HAMA评分、左旋多巴治疗均是影响首诊帕金森患者恐惧疾病进展轨迹类别的影响因素(P＜0.05)。结论年龄＞70岁、PSQI评分≥5分、H＆Y 分级3~5级、HAMA评分＞14分、未进行左旋多巴治疗均是影响首诊帕金森患者恐惧疾病进展轨迹类别的影响因素,建议根据以上危险因素进行针对性地干预。

关键词: 首诊, 帕金森, 恐惧疾病进展, 影响因素, 纵向研究

Abstract: Objective To investigate the longitudinal study of the factors influencing the fear of disease progression disease in patients with first diagnosis of Parkinson's. Methods This study is a longitudinal study,selecting patients admitted to our hospital from January 2020 to December 2023 with a clear first diagnosis of Parkinson's as the study object,using the general information questionnaire respectively in the first for the first diagnosis (T1),2 months after diagnosis (T2),4 months after diagnosis (T3),6 months after diagnosis (T4) tracking follow-up survey,to identify first diagnosis of Parkinson's with latent category modeling patients' fear of disease progression change trajectories,and logistic regression was used to analyze the factors influencing patients' fear of disease progression trajectories. Results A total of 2 trajectories of change in fear of disease progression scores were identified based on the first diagnosis of Parkinson's patients,59.35% (92/155) in the high level fear of disease progression slow decline group,and 40.65% (63/155) in the medium level fear of disease progression stable group.The results of the logistic regression analysis showed that,using the medium-stable group as a reference,the patients in the high fear of disease progression slow Age,PSQI score,H&Y grading,HAMA score,and levodopa treatment of patients in the descending group were influential factors affecting the category of fear of disease progression trajectory in patients with first diagnosis of Parkinson's (P＜0.05). Conclusion Age >70 years,PSQI score ≥5,H&Y score 3-5,HAMA score >14,and no levodopa treatment are influential factors affecting the category of fear of disease progression trajectory in first-diagnosis Parkinson's patients,and it is recommended that interventions be targeted according to the above risk factors.

Key words: First diagnosis, Parkinson's, Fear of disease progression, Influencing factors, Longitudinal study

中图分类号:

742.5

甄苏萌, 胡方婷, 王晶. 首诊帕金森病患者恐惧疾病进展疾病影响因素的纵向研究[J]. 立体定向和功能性神经外科杂志, 2025, 38(2): 71-76.

Zhen Sumeng, Hu Fangting, Wang Jing. A longitudinal study of disease influencing factors for fear of disease progression in first diagnosis Parkinson's patients[J]. Chinese Journal of Stereotactic and Functional Neurosurgery, 2025, 38(2): 71-76.

参考文献

[1] Ye H,Robak LA,Yu MG,et al.Genetics and Pathogenesis of Parkinson's Syndrome[J].Annu Rev Pathol,2023,18:95~121.
[2] Jankovic J,Tan EK.Parkinson's disease:etiopathogenesis and treatment[J].J Neurol Neurosurg Psychiatry,2020,91(8):795~808.
[3] McDaniels B,Subramanian I,Kurian S,et al.Early-onset Parkinson's disease:an assessment of unmet psychosocial needs[J].Parkinsonism Relat Disord,2023,110(1):105395.
[4] Barter JD,Thomas D,Ni L,et al.Parkinson's disease and diabetes mellitus:individual and combined effects on motor,cognitive,and psychosocial functions[J].Healthcare (Basel).2023,11(9):1316.
[5] Sharif-Nia H,Sobhanian P,Froelicher ES,et al.A validity and reliability evaluation of fear of progression questionnaire in Iranian breast cancer patients:a methodological study[J].Health Sci Rep,2024,21,7(7):e2260.
[6] 樊瑞,景鹏宇,郅晓燕.自我效能和家庭支持在经外周静脉置入中心静脉导管患者疾病恐惧与护理依从性的中介效应分析[J].实用医院临床杂志,2023,20(1):96~99.
[7] 李艳艳,单岩,杜理平,等.慢性肾脏病病人与其配偶恐惧疾病进展的相关性[J].护理研究,2019,33(23):4033~4037.
[8] Hughes AJ,Daniel SE,Kilford L,et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease:a clinico-pathological study of 100 cases[J].J Neurol Neurosurg Psychiatry,1992,55(3):181~184.
[9] 万赢,肖仁清,赵嘉豪,等.帕金森病运动并发症风险分层治疗方案的疗效评价[J].中华医学杂志,2022,102(7):491~498.
[10] 焦悦,李娟,吴铁妤,等.帕金森病流涎的发生机制及相关因素分析[J].安徽医科大学学报,2021,56(8):1300~1304.
[11] 李文波,许明智,贾福军,等.汉密顿抑郁量表6项版本的临床应用[J].中国神经精神疾病杂志,2007,33(2):119~120.
[12] 蔺国宪,刘士协,杨德森,等.汉密顿焦虑量表(HAMA)在神经症中的应用[J].中华神经精神科杂志,1986,19(6):342~344.
[13] 黄静,张玉虎,聂坤,等.帕金森病伴认知障碍患者的睡眠质量分析[J].中华神经科杂志,2014,47(7):501~504.
[14] Hasannezhad Reskati M,Elyasi F,Hosseini SH,et al.The psychometric properties of the fear of progression questionnaire (FoP-Q) for cancer patients in Iran[J].J Gastrointest Cancer,2023,54(3):855~866.
[15] 吴奇云,叶志霞,李丽,等.癌症患者恐惧疾病进展简化量表的汉化及信效度分析[J].中华护理杂志,2015,50(12):1515~1519.
[16] Carey G,Lopes R,Viard R,et al.Anxiety in Parkinson's disease is associated with changes in the brain fear circuit[J].Parkinsonism Relat Disord,2020,80(1):89~97.
[17] 李璐璐,李小妹,韩冬芳,等.乳腺癌患者心理痛苦轨迹及影响因素的纵向研究[J].中华护理杂志,2020,55(8):1140~1146.
[18] 承红,毛浩,吴艳,等.帕金森病患者的心理状态分析和心理护理[J].实用临床医药杂志,2009,13(24):105~106.
[19] 张云,管昭锐,白雅,等.多系统萎缩临床特征、诊断时程影响因素及误诊原因分析[J].临床误诊误治,2019,32(5):17~23.
[20] 张扬,冒萧萧,管得宁,等.帕金森病患者跌倒恐惧的临床特征及危险因素分析[J].中国临床研究,2017,30(12):1608~1611.
[21] 曹以婷,刘卫国,郭志颖,等.初诊帕金森病患者小幻觉患病率和相关危险因素分析[J].临床神经病学杂志,2024,37(2):86~90.